Hyperlipidemia Clinical Trial Patient Recruitment

Hyperlipidemia patient recruitment for LDL-lowering, PCSK9 inhibitor, and cardiovascular risk reduction trials.

Who qualifies: Adults with elevated LDL-C (≥70–190 mg/dL) with or without statin intolerance.

Recruitment challenges: Fasting lipid panel requirements and prior statin therapy eligibility criteria.

Our approach: Primary care, cardiology, and endocrinology referral networks with lipid panel pre-screening.